Sinolink: The end of year centralized purchasing expectations are gradually being cleared, and the pharmaceutical sector行情 is expected to gradually start.

The pharmaceutical Sector is currently in a process of a triple reversal in performance, policies, and funding, with full confidence in the recovery of revenue profit growth and market resurgence of listed companies in the Sector by 2025.

Zhitong Finance14:21

Express News | Ping An Securities Pharmaceutical Industry 2025 Annual Strategy Report: Exploring new growth from payment sources, focusing on innovation, going overseas, equipment upgrades, and Consumer recovery.

BreakingsDec 15 12:17

Express News | CITIC Construction Investment: Optimistic about investment opportunities in the pharmaceutical industry in 2025, focusing on new volume and industry integration opportunities

BreakingsDec 12 07:38

Gloria Ying: Some directors, senior management and core technical and business personnel increased their holdings of the company by 23.2638 million yuan

Gelonghui reported on December 11 that Asymchem Laboratories (002821.SZ) announced that as of the date of this announcement, the implementation period of this Shareholding plan has passed halfway. Some Directors, senior management, and other core technical and business personnel have cumulatively increased their holdings of the company’s shares by 344,194 shares through the centralized bidding trading system of the Shenzhen Exchange, accounting for 0.0936% of the current total share capital of the company, with a total increase amount of 23.2638 million yuan.

Gelonghui FinanceDec 11 19:01

Express News | The tenth batch of national centralized procurement will open bids in Shanghai tomorrow: involving 62 varieties, with strict measures to prevent companies from colluding and manipulating the bidding.

BreakingsDec 11 17:13

Is the bearish impact fading? Hong Kong stocks in the pharmaceutical sector are collectively strengthening, with wuxi bio rising over 9% and wuxi apptec rising over 7%.

① How much impact did the biological safety legislation have on domestic pharmaceutical stocks previously? ② How do industry insiders view the subsequent development of the biological legislation?

cls.cnDec 9 10:56